Literature DB >> 26071317

Relationships between major epitopes of the IA-2 autoantigen in Type 1 diabetes: Implications for determinant spreading.

Kerry A McLaughlin1, Carolyn C Richardson1, Stefan Williams1, Ezio Bonifacio2, Diana Morgan3, Richard G Feltbower3, Michael Powell4, Bernard Rees Smith4, Jadwiga Furmaniak4, Michael R Christie5.   

Abstract

Diversification of autoimmunity to islet autoantigens is critical for progression to Type 1 diabetes. B-cells participate in diversification by modifying antigen processing, thereby influencing which peptides are presented to T-cells. In Type 1 diabetes, JM antibodies are associated with T-cell responses to PTP domain peptides. We investigated whether this is the consequence of close structural alignment of JM and PTP domain determinants on IA-2. Fab fragments of IA-2 antibodies with epitopes mapped to the JM domain blocked IA-2 binding of antibodies that recognise epitopes in the IA-2 PTP domain. Peptides from both the JM and PTP domains were protected from degradation during proteolysis of JM antibody:IA-2 complexes and included those representing major T-cell determinants in Type 1 diabetes. The results demonstrate close structural relationships between JM and PTP domain epitopes on IA-2. Stabilisation of PTP domain peptides during proteolysis in JM-specific B-cells may explain determinant spreading in IA-2 autoimmunity.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoantibody; Determinant spreading; Epitope; Monoclonal antibody; Type 1 diabetes

Mesh:

Substances:

Year:  2015        PMID: 26071317     DOI: 10.1016/j.clim.2015.06.002

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  5 in total

1.  Immunoreactivities Against Different Tyrosine-Phosphatase 2 (IA-2)(256-760) Protein Domains Characterize Distinct Phenotypes in Subjects With LADA.

Authors:  Claudio Tiberti; Luca D'Onofrio; Francesca Panimolle; Simona Zampetti; Ernesto Maddaloni; Raffaella Buzzetti
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-24       Impact factor: 6.055

2.  Isolation of human monoclonal autoantibodies derived from pancreatic lymph node and peripheral blood B cells of islet autoantibody-positive patients.

Authors:  Mara Catani; Denise Walther; Michael R Christie; Kerry A McLaughlin; Ezio Bonifacio; Anne Eugster
Journal:  Diabetologia       Date:  2016-02       Impact factor: 10.122

Review 3.  Islet Autoantibodies.

Authors:  Vito Lampasona; Daniela Liberati
Journal:  Curr Diab Rep       Date:  2016-06       Impact factor: 4.810

4.  Identification of Unique Antigenic Determinants in the Amino Terminus of IA-2 (ICA512) in Childhood and Adult Autoimmune Diabetes: New Biomarker Development.

Authors:  Maria Acevedo-Calado; Eddie A James; Michael P Morran; Susan L Pietropaolo; Qin Ouyang; David Arribas-Layton; Marco Songini; Marco Liguori; Anna Casu; Richard J Auchus; Shuai Huang; Liping Yu; Aaron Michels; Roberto Gianani; Massimo Pietropaolo
Journal:  Diabetes Care       Date:  2017-02-07       Impact factor: 19.112

5.  Influence of HLA-DR and -DQ alleles on autoantibody recognition of distinct epitopes within the juxtamembrane domain of the IA-2 autoantigen in type 1 diabetes.

Authors:  Carolyn C Richardson; Kerry A McLaughlin; Diana Morgan; Richard G Feltbower; Michael R Christie
Journal:  Diabetologia       Date:  2015-11-13       Impact factor: 10.122

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.